Research

September 17, 2015

Heart repair factor

A signaling factor called Wnt10b is a novel target for optimizing cardiac repair after a heart attack.

By Yan Su
September 17, 2015

Study shows lower systolic BP targets reduce death risk

The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older.

By Kathy Whitney
Kennedy Center exterior
September 17, 2015

Vanderbilt Kennedy Center to continue as national Developmental Disabilities Research Center

The Vanderbilt Kennedy Center (VKC) has been awarded a $6.5 million, five-year grant to continue as a national Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center (IDDRC).

By VUMC News and Communications
Craig Hutto and Michael Goldfarb
September 10, 2015

Surgery and engineering initiative becomes institute

VISE is keeping its acronym but changing its name. The Vanderbilt Initiative in Surgery and Engineering will become the Vanderbilt Institute in Surgery and Engineering.

By VUMC News and Communications
genetic sequence
September 10, 2015

Grants spur effort to add genetic data to EMR

Vanderbilt University researchers have received two major federal grants — totaling $7.6 million over four years — to support groundbreaking research aimed at making genetic information a routine part of patients’ electronic medical records.

By Bill Snyder
Insulin in vials
September 10, 2015

Diabetes trial targets body’s ability to produce insulin

Kiersten Eaddy had long looked forward to her high school graduation day and joining her classmates to celebrate the accomplishment.

By VUMC News and Communications
September 10, 2015

Initiative seeks to bolster ‘rediscovery research’

The Vanderbilt Institute for Clinical and Translational Research (VICTR) is partnering with a public charity, Cures Within Reach, to encourage “rediscovery research,” the “repurposing” of already approved medical treatments to other conditions or diseases for which there are no “universally” effective therapies.
By Bill Snyder
September 10, 2015

Gifford, Bell land development awards in aging research

Two faculty members of the Vanderbilt Memory and Alzheimer’s Center are among a handful of 2015 scholars for the Paul B. Beeson Career Development Awards in Aging Research Program.
By Tom Wilemon
September 10, 2015

Ebola symposium to feature Nigerian physicians

Three Nigerian physicians who survived Ebola virus disease in July 2014 after coming in direct contact with an Ebola-infected patient will speak at Vanderbilt University Medical Center next Wednesday, Sept. 16.
By Bill Snyder
September 9, 2015

How to build a basement

Understanding the action of a certain enzyme will shed light on basement membrane function, and on disorders ranging from diabetic kidney disease to cancer.
By Sanjay Mishra
September 9, 2015

Vanderbilt earns best-ever No. 15 ranking from ‘U.S. News & World Report’

Vanderbilt was ranked No. 15 on "U.S. News & World Report's" list of top national universities, its best-ever showing.
By VUMC News and Communications
September 8, 2015

Immune cells and obesity

Understanding how macrophage immune cells accumulate in fat tissue and contribute to the pathology of obesity could lead to the development of novel therapeutics for metabolic disorders.
By Leigh MacMillan
September 4, 2015

Vitamin C protects blood vessel lining

Dietary vitamin C may maintain healthy blood vessels in patients with inflammatory diseases.
By Leigh MacMillan